111, Inc. (YI)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$6.57
-4.09%
Mkt Cap $60.16M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 9, 2026 | $599.57M | $403.17M | -32.76% | — | -$0.20 | — | — | — |
| Q4 2025 Dec 17, 2025 | $551.19M | $421.47M | -23.54% | — | -$0.20 | — | — | — |
| Q3 2025 Sep 17, 2025 | $520.94M | $447.04M | -14.19% | — | -$0.40 | — | — | — |
| Q2 2025 Jun 19, 2025 | $529.82M | $484.71M | -8.51% | — | -$0.20 | — | — | — |
| Q1 2025 Mar 20, 2025 | $542.09M | $526.99M | -2.78% | — | -$0.04 | — | — | — |
| Q4 2024 Nov 27, 2024 | $4.25B | $513.13M | -87.92% | — | -$0.20 | — | — | — |
| Q3 2024 Aug 29, 2024 | $487.99M | $471.23M | -3.43% | — | -$0.20 | — | — | — |
| Q2 2024 May 23, 2024 | — | $487.84M | — | — | -$0.20 | — | — | — |
| Q1 2024 Mar 21, 2024 | — | $580.11M | — | — | -$3.40 | — | — | — |
| Q4 2023 Nov 30, 2023 | — | $501.70M | — | — | -$1.60 | — | — | — |
| Q3 2023 Aug 24, 2023 | — | $479.98M | — | — | -$1.00 | — | — | — |
| Q2 2023 Jun 15, 2023 | — | $537.63M | — | — | -$0.60 | — | — | — |
| Q1 2023 Mar 23, 2023 | — | $605.88M | — | — | -$2.00 | — | — | — |
| Q4 2022 Dec 1, 2022 | — | $468.72M | — | — | -$1.60 | — | — | — |
| Q2 2022 Jun 16, 2022 | $15.04B | $469.42M | -96.88% | — | -$2.00 | — | — | — |
| Q1 2022 Mar 17, 2022 | $472.89M | $543.44M | +14.92% | — | -$2.20 | — | — | — |
| Q4 2021 Nov 19, 2021 | — | $518.48M | — | — | -$4.80 | — | — | — |
| Q2 2021 May 19, 2021 | $1.69B | $395.21M | -76.66% | — | -$2.80 | — | — | — |
| Q1 2021 Mar 18, 2021 | — | $404.87M | — | — | -$2.40 | — | — | — |
| Q4 2020 Nov 19, 2020 | — | $347.65M | — | — | -$2.00 | — | — | — |